DFIN has had quite a week. On Wednesday, the company announced its quarterly financial results – highlighted by a nearly 28 percent growth in our software solutions sales. You can read the press release here.
DFIN Financial Transparency Act Blog
DFIN Supports Reintroduction of the Financial Transparency Act (FTA) to Help Bring Financial Transparency to Financial Markets and Foster Economic Growth and Capital Formation for Industry
I’ve been in the financial industry a long time. Some may disagree, but I believe in transparency. I believe it enables businesses, organizations—and governments—to work better, together.
AI and Remote Work in the Legal Industry
With the tragic Covid-19 pandemic since last year, the emergence of remote-based work is now fully upon us. Like any working environment, this “new normal” has its plusses and minuses. Viewing the glass half-full, remote work has allowed employees the chance to spend less time commuting and more time on productivity. On the other hand, it can be difficult to achieve the same level of personal camaraderie amongst a project team, for instance, when all of its members are physically separated.
2021 SPAC Market Update and Opportunities for Asia Pacific
The special purpose acquisition company (SPAC) market has boomed over the past several years, with continued increases in IPO activity and record completions of de-SPAC transactions. More than 50% of total IPOs in 2020 were SPACs, this represents a 4x increase from the previous year. As of March 25, 2021, 445 SPACs have filed with the SEC with 296 SPACs pricing, raising over $89 billion*. This surpasses 2020's record number of 248 SPACs raising over $76 billion* for the full year of 2020.
2021 Proxy Season Trends
Diversity, pandemic pay and climate risk: Trends to watch this proxy season
This is the time of year when we in New York wonder if spring ever will arrive. But arrive it will, and fast on its heels will come corporate proxy season.
Hot SPAC Market Confronts Chilly SEC Rule Change
Author: Craig Clay
SPAC records were crushed in Q-1 by count and value with roughly $88B raised from 298 SPACs, more than all of last year’s record volume. With the news today of a potential change in accounting for some SPACs recommended by the SEC – what will happen to the robust pipeline of more than 260 SPACs looking to make their debut?
Industry Roundtable: Beyond LIBOR: Developments, Lessons & Opportunities
Recent regulatory developments have the potential to impact LIBOR transition plans. In addition to navigating these changes, some business leaders are thinking about what comes next - not just for alternative interest rates, but also for future opportunities regarding the processes and technology implemented during the challenging LIBOR transition. Rather than simply being a cost, the innovation required for LIBOR transition could help digitally transform and create greater efficiency in many parts of an organization.
Craig Clay, president of global capital markets at Donnelley Financial Solutions (DFIN), a Chicago-based financial compliance company, speaks with Acuris Capital Intelligence about virtual data rooms—one of their core products—post-COVID-19 as well as its partnership strategy.
Interview by Rachel Stone
Q. What has changed in the M&A process during the pandemic?
The coronavirus pandemic has disrupted trading relationships worldwide – and as a consequence, enterprise contract review, negotiation and renegotiation of contracts are taking place on a massive scale. Donnelley Financial Solutions (DFIN) was invited to participate in an international conversation to address the challenges and opportunities of enterprise contract management during and beyond the COVID-19 pandemic.
Donnelley Financial could pursue more partnerships to grow tech offering, executive says
Donnelley Financial Solutions [NYSE:DFIN], a risk and compliance solutions company, could seek partnerships to further build out its technology offering, said Craig Clay, president of global capital markets.
The Chicago-based company could turn to partnerships rather than acquisitions as assets can be “pretty expensive,” Clay said. On its path to becoming a one-stop shop for transactions, it could, for instance, consider partnering with a market leader in US Food and Drug Administration (FDA) approvals, he added.